Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GMVDF NASDAQ:IONM NASDAQ:NAYA NASDAQ:OSA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGMVDFG Medical Innovations$0.00$0.00▼$0.02$26K40.2810,023 shsN/AIONMAssure$0.03$0.04$0.03▼$0.55$91K190.366,801 shsN/ANAYANAYA Biosciences$0.82+2.2%$1.39$1.38▼$17.04$546K2.0353,151 shs84,593 shsOSAProSomnus$0.41$0.35▼$5.25$237K0.2165,686 shs5 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGMVDFG Medical Innovations0.00%0.00%0.00%-50.00%-98.89%IONMAssure0.00%0.00%-39.33%+28,900.00%-99.37%NAYANAYA Biosciences+2.24%-4.55%-37.41%-57.30%+81,989,900.00%OSAProSomnus0.00%0.00%0.00%0.00%+120.78%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGMVDFG Medical InnovationsN/AN/AN/AN/AN/AN/AN/AN/AIONMAssureN/AN/AN/AN/AN/AN/AN/AN/ANAYANAYA BiosciencesN/AN/AN/AN/AN/AN/AN/AN/AOSAProSomnusN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGMVDFG Medical Innovations 0.00N/AN/AN/AIONMAssure 0.00N/AN/AN/ANAYANAYA Biosciences 3.00Buy$24.002,827.19% UpsideOSAProSomnus 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGMVDFG Medical Innovations$4.42M0.00N/AN/AN/ANaNIONMAssure$149K0.61N/AN/A($41.04) per share0.00NAYANAYA Biosciences$6.23M0.09N/AN/A($2.06) per share-0.40OSAProSomnus$27.65M0.00N/AN/A($2.33) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGMVDFG Medical Innovations-$24.63MN/A0.00N/AN/AN/AN/AN/AN/AIONMAssure-$26.08MN/A0.00∞N/A-25,178.32%N/A-249.78%N/ANAYANAYA Biosciences-$8.03MN/A0.00∞N/A-119.91%N/A-41.72%8/12/2025 (Estimated)OSAProSomnus-$24.09M-$1.56N/AN/AN/A-87.14%N/A-106.30%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGMVDFG Medical InnovationsN/AN/AN/AN/AN/AIONMAssureN/AN/AN/AN/AN/ANAYANAYA BiosciencesN/AN/AN/AN/AN/AOSAProSomnusN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGMVDFG Medical InnovationsN/AN/AN/AIONMAssureN/A0.200.20NAYANAYA BiosciencesN/A0.230.20OSAProSomnusN/A1.000.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGMVDFG Medical Innovations5.96%IONMAssure3.33%NAYANAYA Biosciences12.02%OSAProSomnus70.03%Insider OwnershipCompanyInsider OwnershipGMVDFG Medical Innovations37.10%IONMAssure3.80%NAYANAYA Biosciences1.79%OSAProSomnus7.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGMVDFG Medical Innovations72259.92 million163.49 millionNot OptionableIONMAssure1303.13 million3.02 millionNot OptionableNAYANAYA Biosciences10666,0004.40 millionN/AOSAProSomnus13617.39 million16.06 millionNot OptionableOSA, NAYA, IONM, and GMVDF HeadlinesRecent News About These CompaniesSleep Apnea Oral Appliances Market to Hit USD 746.6 Million by 2029 with 9.6% CAGR | MarketsandMarkets™October 2, 2024 | finance.yahoo.comProSomnus Sleep Technologies, Inc.: ProSomnus Sleep Technologies Announces Record Revenues as it Emerges from ReorganizationAugust 8, 2024 | finanznachrichten.deStudy identifies first drug therapy for sleep apneaJuly 19, 2024 | sciencedaily.comSProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual MeetingMay 13, 2024 | finance.yahoo.comFour Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical DevicesMay 9, 2024 | finance.yahoo.comProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term SuccessMay 9, 2024 | markets.businessinsider.comProSomnus, Inc. (OSA) Interactive Stock Chart - Yahoo FinanceApril 20, 2024 | finance.yahoo.comProSomnus (OSA) Price Target Increased by 38.89% to 2.55April 17, 2024 | msn.comThe Power of Oral Appliances: Navigating the Sleep Apnea MarketApril 11, 2024 | pharmiweb.comPProSomnus Sleep Technologies, Inc.: ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 31, 2024 | finanznachrichten.deProSomnus, Inc. Common Stock (NASDAQ:OSA) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | finance.yahoo.comOSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023March 28, 2024 | investorplace.comQ4 2023 Prosomnus Inc Earnings CallMarch 27, 2024 | finance.yahoo.comProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 26, 2024 | globenewswire.comProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update CallMarch 15, 2024 | globenewswire.comProSomnus reports pilot study data for remote OSA monitoring deviceFebruary 23, 2024 | msn.comTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)February 23, 2024 | benzinga.comProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep ApneaFebruary 22, 2024 | finance.yahoo.comProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep ApneaFebruary 22, 2024 | globenewswire.comProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024February 20, 2024 | finance.yahoo.comMedia Sentiment Over TimeOSA, NAYA, IONM, and GMVDF Company DescriptionsG Medical Innovations NASDAQ:GMVDFG Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.Assure NASDAQ:IONM$0.03 0.00 (0.00%) As of 07/16/2025Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.NAYA Biosciences NASDAQ:NAYA$0.82 +0.02 (+2.24%) As of 07/16/2025NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.ProSomnus NASDAQ:OSAProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
